Skip to content
Hi-Doctor

How to Get Retatrutide Online in Varaždin

Seeking Retatrutide online in Varaždin, Croatia? While interest in this new weight-loss peptide is high, Retatrutide is not currently approved for prescription in the EU and is not offered by Hi-Doctor.

23 April 2026
How to Get Retatrutide Online in Varaždin —

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Less than 4 hours on average

Prescription issued in less than 4 hours on average if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

In this article

If you're searching for Retatrutide online in Varaždin, Croatia, it's important to understand its current status. Retatrutide is an investigational medication, still undergoing clinical trials, and is not yet approved for weight-loss prescription in the European Union. Consequently, Hi-Doctor does not currently prescribe or offer Retatrutide. This article will explain what Retatrutide is, why it isn't a readily available option today, and what safe, EU-approved weight-loss treatments you CAN access through an EU-licensed doctor.

What is Retatrutide, and why isn't it a normal option yet?

Retatrutide is an experimental drug known as a triple agonist, targeting three different receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. This unique combination aims to enhance weight loss and improve metabolic health more comprehensively than existing single or dual-agonist therapies. While early clinical trial results have shown promising efficacy for significant weight reduction, Retatrutide has not yet received regulatory approval from the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA) for widespread clinical use. Until it completes all trial phases and secures official approval, it remains unavailable by prescription. Attempting to acquire Retatrutide from unregulated online sources or 'research chemical' vendors carries significant safety risks, as these products may be counterfeit, contaminated, incorrectly dosed, or lack any medical oversight.

Proven weight-loss medications available online today

While Retatrutide is still in development, several highly effective and EU-approved medications are available for weight management, prescribed by licensed doctors based on your individual health needs:

  • Ozempic (semaglutide): Primarily approved for type 2 diabetes, Ozempic also aids weight loss and can be prescribed off-label by EU-licensed doctors when clinically appropriate for weight management.
  • Wegovy (semaglutide, higher-dose): This is the higher-dose formulation of semaglutide, specifically approved and indicated for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
  • Mounjaro (tirzepatide): A dual GLP-1 and GIP receptor agonist, Mounjaro is approved for type 2 diabetes and is increasingly recognized for its significant weight-loss benefits, with specific weight-loss indications expected soon.
  • Saxenda (liraglutide): An earlier GLP-1 receptor agonist, Saxenda is approved for chronic weight management and is often suitable for patients who may not tolerate other options or for whom other options are not indicated.

How to get a weight-loss prescription online in Varaždin, Croatia

Getting a safe and legitimate weight-loss prescription through Hi-Doctor is a straightforward 4-step process, accessible from Varaždin or anywhere in the EU:

  1. Complete an online medical questionnaire: In just 2-3 minutes, provide details about your health, medical history, and weight-loss goals.
  2. EU-licensed doctor reviews your case: Our doctors, all licensed in the EU, will carefully assess your information to determine if a weight-loss treatment is safe and appropriate for you.
  3. Receive your REMPE prescription: If approved, you'll receive a Spanish standard REMPE electronic prescription (valid EU-wide) in under 24 hours. This downloadable PDF will be available in your secure patient account and sent via email.
  4. Pick up at any EU pharmacy: Present your electronic prescription at any pharmacy in any EU country, including Croatia, thanks to cross-border prescription directive 2011/24/EU.

The online consultation costs a flat €25. If our doctor determines treatment is not appropriate for you, your €25 fee is automatically refunded, ensuring a risk-free assessment.

Why choose Hi-Doctor over unregulated peptide sellers

When considering weight-loss treatments, safety and legitimacy are paramount. Hi-Doctor offers a regulated, medically supervised path, in stark contrast to unregulated peptide sellers:

  • EU-licensed doctors: Your case is reviewed by real, qualified medical professionals licensed within the European Union.
  • Real medications: We prescribe only EU-approved, traceable medications, not 'research chemicals' or unverified compounds.
  • Legitimate pharmacies: Prescriptions are filled at any licensed EU pharmacy, ensuring product quality and safety.
  • Auditable, RGPD-compliant chat: All communications are secure and adhere to strict data privacy regulations.
  • Trusted service: With over 50,000 patients served and a 4.8 Trustpilot rating, our reputation speaks for itself.

Unlike grey-market vendors, Hi-Doctor provides medical oversight, ensuring that any treatment is appropriate for your health and comes from a verified source.

COMMON QUESTIONS

Frequently asked questions

No, Retatrutide is not legally approved for prescription or sale in Croatia or any other EU country at this time. Acquiring it from unregulated online sources carries significant legal and health risks.

Licensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account
Online Doctor Legitimacy and EU Regulations Explained — article cover image

Online Doctor Legitimacy and EU Regulations Explained

This article clarifies the legitimacy of online doctor services within the European Union, detailing the regulations that ensure patient safety and the validity of cross-border prescriptions.

14 August 2026
Understanding REMPE Electronic Prescriptions: A Guide for EU Patients — article cover image

Understanding REMPE Electronic Prescriptions: A Guide for EU Patients

This guide explains the Spanish REMPE electronic prescription system, its function within Spain, and its recognition across the EU. It clarifies how these prescriptions are reviewed and processed by pharmacists, both.

13 August 2026
Zavamed Alternatives: 8 Options Compared (2026) — article cover image

Zavamed Alternatives: 8 Options Compared (2026)

Looking for Zavamed alternatives in 2026? We compare 8 online health services by market, treatment coverage and supported consultation or fulfilment model.

6 August 2026
Dokteronline Alternatives: 8 Options Compared (2026) — article cover image

Dokteronline Alternatives: 8 Options Compared (2026)

Looking for Dokteronline alternatives? We compare 8 online healthcare services across the EU, UK and US, with clear market labels and service-model differences.

6 August 2026
Best Telehealth Men's Health Services in Spain (2026) — article cover image

Best Telehealth Men's Health Services in Spain (2026)

We compare seven telehealth men's health services available in Spain in 2026, from EU e-prescription platforms to doctor-directory and generalist services covering sexual health, hair growth and weight management.

6 August 2026
Best Online ED Treatment Providers in Europe (2026) — article cover image

Best Online ED Treatment Providers in Europe (2026)

Compare the top online ED treatment providers in Europe for 2026. We evaluate services by their consultation model, market availability, and approach to sexual healthcare.

6 August 2026

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.